FERRARO, MARIA
FERRARO, MARIA
FARMACOLOGIA TRASLAZIONALE - IFT
"Effects of formoterol on the molecular mechanisms of corticosteroid resistance in models with high oxidative stress"
2014 FERRARO M.; GJOMARKAJ M.; DI VINCENZO S.; BALSAMO R.; PACE E.
2-DE reveals proteasome impairment in 16-HBE cells after LPS and CSE exposure
2016 D'Anna, C; Cigna, D; Di Sano, C; Ferraro, M; Bianchi, L; Bini, L; Gjomarkaj, Mark; Pace, E
[P4735] Fluticasone furoate maintains epithelial homeostasis via leptin/leptin receptor pathway in nasal cells
2013 Bruno, Andreina; Gerbino, Stefania; Ferraro, Maria; Siena, Liboria; Bonura, Angela; LA GRUTTA, Stefania; Gjomarkaj, Mark; Pace, Elisabetta; Colombo, Paolo
A decreased expression of leptin receptor may contribute to the pathogenesis of the allergic rhinitis
2010 Andreina Bruno; Stefania La Grutta; Maria Ferraro; Stefania Gerbino; Angela Bonura; Paolo Colombo; Mark Gjomarkaj; Elisabetta Pace
Airway inflammation induces the expression of choline acetyltransferase and muscarinic receptors promoting the fibroblast proliferation in COPD subjects
2007 Profita M; Siena L; Bonanno A; Pompeo F; Montalbano A M ; Ferraro M; Bruno A; Bonsignore G; Piper M; Gjomarkaj M.
Alterations of proteomic profile in HFL-1 cells after CSE exposure
2014 D'Anna, C; Cigna, D; Costanzo, G; Bruno, A; Ferraro, M; Di Vincenzo, S; Bianchi, L; Bini, L; Gjomarkaj, Mark; Pace, E
Altered CD94/NKG2A and perforin expression reduce the cytotoxic activity in malignant pleural effusions.
2011 Pace E; Di Sano C; Ferraro M; Tipa A; Olivieri D; Spatafora M; Santagata R; Bellia V; Gjomarkaj M.
Altered expression of TLR4 and of beta defensin 2 in chronic obstructive pulmonary disease
2006 Pace, E; Ferraro, M; Minervini, Mi; Chiappara, G; Montalbano, Am; Siena, L; Pipitone, L; Bonsignore, G; Gjomarkaj, Mark
Altered expression of TLR4 and of beta defensin 2 in chronic obstructive pulmonary disease.
2007 PACE E.; FERRARO M.; MINERVINI MI.; VITULO P.; CHIAPPARA G.; MONTALBANO AM.; PIPITONE L.; JOHNSON M.; CARONIA F.; BONSIGNORE G.; GRIDELLI B.; GJOMARKAJ M.
Anti-inflammatory effects of formoterol and fluticasone propionate in bronchial epithelial cells
2015 FERRARO M.; GJOMARKAJ M.; SIENA L.; DI VINCENZO S.; PACE E.
Anti-inflammatory effects of formoterol and fluticasone propionate in bronchial epithelial cells
2015 FERRARO M.; GJOMARKAJ M.; SIENA L.; DI VINCENZO S.; PACE E.
Anti-inflammatory effects of Omalizumab in severe asthmatics.
2011 Pace, E; Ferraro, M; Bruno, A; Bousquet, J; Gjomarkaj, Mark
Anti-inflammatory effects of seven years treatment with Omalizumab in severe uncontrolled asthmatics.
2010 Pace E ; Ferraro M; Bruno A; Bousquet J; Gjomarkaj M.
Apigenin affects leptin/leptin receptor pathway and induces cell apoptosis in lung adenocarcinoma cell line.
2011 Bruno, A; Siena, L; Gerbino, S; Ferraro, M; Chanez, P; Giammanco, M; Gjomarkaj, Mark; Pace, E
Autocrine Acetylcholine, Induced by IL-17A via NF kappa B and ERK1/2 Pathway Activation, Promotes MUC5AC and IL-8 Synthesis in Bronchial Epithelial Cells
2016 Montalbano, ANGELA MARINA; Albano, GIUSY DANIELA; Bonanno, Anna; Riccobono, Loredana; DI SANO, Caterina; Ferraro, Maria; Siena, Liboria; Anzalone, Giulia; Gagliardo, Rosalia; Paul Pieper, Michael; Gjomarkaj, Mark; Profita, Mirella
Beta defensin-2 is reduced in central but not in distal airways of smoker COPD patients.
2012 Pace E; Ferraro M; Minervini MI; Vitulo P; Pipitone L; Chiappara G; Siena L; Montalbano AM; Johnson M; Gjomarkaj M.
Beta2 long-acting and anticholinergic drugs control TGF-beta1-mediated neutrophilic inflammation in COPD
2012 A, Mirella Profita; A, Anna Bonanno; A, Angela Marina Montalbano; a b, Giusy Daniela Albano; A, Loredana Riccobono; A, Liboria Siena; Ferraro, Maria; C, Paola Casarosa; C, Michael Paul Pieper; Gjomarkaj, Mark
Beta2 long-acting and anticholinergic drugs synergistically control TGFbeta1-mediated neutrophilic inflammation in COPD: An "in vitro" model
2011 M. PROFITA; A. BONANNO; A. M. MONTALBANO; M. FERRARO; G. D. ALBANO; L. RICCOBONO; L. SIENA; M. P. PIEPER; P. CASAROSA; M. GJOMARKAJ
Biocompatible polymers coated Solid Lipid Microparticles (SLM) for pulmonary delivery
2015 Amore, E; Botto, C; Giammona, G; Bondì, Ml; Ferraro, M; Gjomarkaj, Mark; Pace, E
Budesonide increases TLR4 and TLR2 expression in Treg lymphocytes of allergic asthmatics
2015 Elisabetta Pace; Caterina Di Sano; Maria Ferraro; Andreina Bruno; Valentina Caputo; Salvatore Gallina; Mark Gjomarkaj
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| "Effects of formoterol on the molecular mechanisms of corticosteroid resistance in models with high oxidative stress" | 1-gen-2014 | FERRARO M.; GJOMARKAJ M.; DI VINCENZO S.; BALSAMO R.; PACE E. | |
| 2-DE reveals proteasome impairment in 16-HBE cells after LPS and CSE exposure | 1-gen-2016 | D'Anna, C; Cigna, D; Di Sano, C; Ferraro, M; Bianchi, L; Bini, L; Gjomarkaj, Mark; Pace, E | |
| [P4735] Fluticasone furoate maintains epithelial homeostasis via leptin/leptin receptor pathway in nasal cells | 1-gen-2013 | Bruno, Andreina; Gerbino, Stefania; Ferraro, Maria; Siena, Liboria; Bonura, Angela; LA GRUTTA, Stefania; Gjomarkaj, Mark; Pace, Elisabetta; Colombo, Paolo | |
| A decreased expression of leptin receptor may contribute to the pathogenesis of the allergic rhinitis | 1-gen-2010 | Andreina Bruno; Stefania La Grutta; Maria Ferraro; Stefania Gerbino; Angela Bonura; Paolo Colombo; Mark Gjomarkaj; Elisabetta Pace | |
| Airway inflammation induces the expression of choline acetyltransferase and muscarinic receptors promoting the fibroblast proliferation in COPD subjects | 1-gen-2007 | Profita M; Siena L; Bonanno A; Pompeo F; Montalbano A M ; Ferraro M; Bruno A; Bonsignore G; Piper M; Gjomarkaj M. | |
| Alterations of proteomic profile in HFL-1 cells after CSE exposure | 1-gen-2014 | D'Anna, C; Cigna, D; Costanzo, G; Bruno, A; Ferraro, M; Di Vincenzo, S; Bianchi, L; Bini, L; Gjomarkaj, Mark; Pace, E | |
| Altered CD94/NKG2A and perforin expression reduce the cytotoxic activity in malignant pleural effusions. | 1-gen-2011 | Pace E; Di Sano C; Ferraro M; Tipa A; Olivieri D; Spatafora M; Santagata R; Bellia V; Gjomarkaj M. | |
| Altered expression of TLR4 and of beta defensin 2 in chronic obstructive pulmonary disease | 1-gen-2006 | Pace, E; Ferraro, M; Minervini, Mi; Chiappara, G; Montalbano, Am; Siena, L; Pipitone, L; Bonsignore, G; Gjomarkaj, Mark | |
| Altered expression of TLR4 and of beta defensin 2 in chronic obstructive pulmonary disease. | 1-gen-2007 | PACE E.; FERRARO M.; MINERVINI MI.; VITULO P.; CHIAPPARA G.; MONTALBANO AM.; PIPITONE L.; JOHNSON M.; CARONIA F.; BONSIGNORE G.; GRIDELLI B.; GJOMARKAJ M. | |
| Anti-inflammatory effects of formoterol and fluticasone propionate in bronchial epithelial cells | 1-gen-2015 | FERRARO M.; GJOMARKAJ M.; SIENA L.; DI VINCENZO S.; PACE E. | |
| Anti-inflammatory effects of formoterol and fluticasone propionate in bronchial epithelial cells | 1-gen-2015 | FERRARO M.; GJOMARKAJ M.; SIENA L.; DI VINCENZO S.; PACE E. | |
| Anti-inflammatory effects of Omalizumab in severe asthmatics. | 1-gen-2011 | Pace, E; Ferraro, M; Bruno, A; Bousquet, J; Gjomarkaj, Mark | |
| Anti-inflammatory effects of seven years treatment with Omalizumab in severe uncontrolled asthmatics. | 1-gen-2010 | Pace E ; Ferraro M; Bruno A; Bousquet J; Gjomarkaj M. | |
| Apigenin affects leptin/leptin receptor pathway and induces cell apoptosis in lung adenocarcinoma cell line. | 1-gen-2011 | Bruno, A; Siena, L; Gerbino, S; Ferraro, M; Chanez, P; Giammanco, M; Gjomarkaj, Mark; Pace, E | |
| Autocrine Acetylcholine, Induced by IL-17A via NF kappa B and ERK1/2 Pathway Activation, Promotes MUC5AC and IL-8 Synthesis in Bronchial Epithelial Cells | 1-gen-2016 | Montalbano, ANGELA MARINA; Albano, GIUSY DANIELA; Bonanno, Anna; Riccobono, Loredana; DI SANO, Caterina; Ferraro, Maria; Siena, Liboria; Anzalone, Giulia; Gagliardo, Rosalia; Paul Pieper, Michael; Gjomarkaj, Mark; Profita, Mirella | |
| Beta defensin-2 is reduced in central but not in distal airways of smoker COPD patients. | 1-gen-2012 | Pace E; Ferraro M; Minervini MI; Vitulo P; Pipitone L; Chiappara G; Siena L; Montalbano AM; Johnson M; Gjomarkaj M. | |
| Beta2 long-acting and anticholinergic drugs control TGF-beta1-mediated neutrophilic inflammation in COPD | 1-gen-2012 | A, Mirella Profita; A, Anna Bonanno; A, Angela Marina Montalbano; a b, Giusy Daniela Albano; A, Loredana Riccobono; A, Liboria Siena; Ferraro, Maria; C, Paola Casarosa; C, Michael Paul Pieper; Gjomarkaj, Mark | |
| Beta2 long-acting and anticholinergic drugs synergistically control TGFbeta1-mediated neutrophilic inflammation in COPD: An "in vitro" model | 1-gen-2011 | M. PROFITA; A. BONANNO; A. M. MONTALBANO; M. FERRARO; G. D. ALBANO; L. RICCOBONO; L. SIENA; M. P. PIEPER; P. CASAROSA; M. GJOMARKAJ | |
| Biocompatible polymers coated Solid Lipid Microparticles (SLM) for pulmonary delivery | 1-gen-2015 | Amore, E; Botto, C; Giammona, G; Bondì, Ml; Ferraro, M; Gjomarkaj, Mark; Pace, E | |
| Budesonide increases TLR4 and TLR2 expression in Treg lymphocytes of allergic asthmatics | 1-gen-2015 | Elisabetta Pace; Caterina Di Sano; Maria Ferraro; Andreina Bruno; Valentina Caputo; Salvatore Gallina; Mark Gjomarkaj |